ESR1 and breast carcinoma: Other key features to note are that MDA-MB-361 and SKBr3 harbor ERBB2 amplification, MDA-MB-361 was isolated from a breast cancer-derived metastatic brain tumor, and SKBr3 cells do not express estrogen receptor (ER-negative) [44].